2. Academic Validation
  3. Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome

Mutations in EXTL3 Cause Neuro-immuno-skeletal Dysplasia Syndrome

  • Am J Hum Genet. 2017 Feb 2;100(2):281-296. doi: 10.1016/j.ajhg.2017.01.013.
Machteld M Oud 1,  Paul Tuijnenburg 2,  Maja Hempel 3,  Naomi van Vlies 4,  Zemin Ren 5,  Sacha Ferdinandusse 4,  Machiel H Jansen 2,  René Santer 6,  Jessika Johannsen 6,  Chiara Bacchelli 7,  Marielle Alders 8,  Rui Li 9,  Rosalind Davies 7,  Lucie Dupuis 10,  Catherine M Cale 11,  Ronald J A Wanders 4,  Steven T Pals 5,  Louise Ocaka 7,  Chela James 7,  Ingo Müller 12,  Kai Lehmberg 12,  Tim Strom 13,  Hartmut Engels 14,  Hywel J Williams 7,  Phil Beales 7,  Ronald Roepman 15,  Patricia Dias 16,  Han G Brunner 15,  Jan-Maarten Cobben 17,  Christine Hall 18,  Taila Hartley 19,  Polona Le Quesne Stabej 7,  Roberto Mendoza-Londono 10,  E Graham Davies 20,  Sérgio B de Sousa 21,  Davor Lessel 3,  Heleen H Arts 22,  Taco W Kuijpers 23
Affiliations

Affiliations

  • 1 Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands. Electronic address: [email protected].
  • 2 Department of Experimental Immunology, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands; Department of Pediatric Hematology, Immunology, and Infectious disease, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands.
  • 3 Institute of Human Genetics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • 4 Laboratory Genetic Metabolic Diseases, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands.
  • 5 Department of Pathology, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, the Netherlands.
  • 6 Department of Pediatrics, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • 7 COSgene, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK.
  • 8 Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, PO Box 22660, 1100 DD Amsterdam, the Netherlands.
  • 9 Department of Human Genetics, McGill University, Montreal, QC H3A 1B1, Canada; McGill University and Génome Québec Innovation Centre, Montreal, QC H3A 0G1, Canada.
  • 10 Division of Clinical and Metabolic Genetics, Department of Paediatrics, The Hospital for Sick Children and University of Toronto, Toronto, ON M5G 1X8, Canada.
  • 11 Department of Immunology, Great Ormond Street Hospital, WC1N 3JH London, UK.
  • 12 Division of Pediatric Stem Cell Transplantation and Immunology, University Medical Center Hamburg-Eppendorf, 20246 Hamburg, Germany.
  • 13 Institute of Human Genetics, Helmholtz Zentrum München, 85764 Neuherberg, Germany; Institute of Human Genetics, Technische Universität München, 81675 München, Germany.
  • 14 Institute of Human Genetics, University of Bonn, 53127 Bonn, Germany.
  • 15 Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands.
  • 16 Serviςo de Genética, Departamento de Pediatria, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Centro Académico de Medicina de Lisboa, 1640-035 Lisboa, Portugal.
  • 17 Department of Pediatrics, Academic Medical Center University Hospital, PO Box 22660, 1100 DD Amsterdam, the Netherlands; Department of Clinical Genetics, St. George's University Hospital, SW19 0ER London, UK.
  • 18 Emerita, Department of Radiology, Great Ormond Street Hospital, WC1N 3JH London, UK.
  • 19 Children's Hospital of Eastern Ontario Research Institute, Ottawa, ON K1H 8 L1, Canada.
  • 20 COSgene, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK; Department of Immunology, Great Ormond Street Hospital, WC1N 3JH London, UK.
  • 21 COSgene, Great Ormond Street Institute of Child Health, University College London, WC1N 1EH London, UK; Medical Genetics Unit, Hospital Pediátrico, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal; Faculty of Health Sciences, University of Beira Interior, 6200-506 Covilhã, Portugal.
  • 22 Department of Human Genetics, Radboud Institute for Molecular Life Sciences, Radboud University Medical Centre, PO Box 9101, 6500 HB Nijmegen, the Netherlands; Department of Pathology and Molecular Medicine, McMaster University Medical Centre, Hamilton, ON L8S 4J9, Canada.
  • 23 Department of Experimental Immunology, Academic Medical Centre, PO Box 22660, 1100 DD Amsterdam, the Netherlands. Electronic address: [email protected].
PMID: 28132690 DOI: 10.1016/j.ajhg.2017.01.013
Abstract

EXTL3 regulates the biosynthesis of heparan sulfate (HS), important for both skeletal development and hematopoiesis, through the formation of HS proteoglycans (HSPGs). By whole-exome sequencing, we identified homozygous missense mutations c.1382C>T, c.1537C>T, c.1970A>G, and c.2008T>G in EXTL3 in nine affected individuals from five unrelated families. Notably, we found the identical homozygous missense mutation c.1382C>T (p.Pro461Leu) in four affected individuals from two unrelated families. Affected individuals presented with variable skeletal abnormalities and neurodevelopmental defects. Severe combined immunodeficiency (SCID) with a complete absence of T cells was observed in three families. EXTL3 was most abundant in hematopoietic stem cells and early progenitor T cells, which is in line with a SCID phenotype at the level of early T cell development in the thymus. To provide further support for the hypothesis that mutations in EXTL3 cause a neuro-immuno-skeletal dysplasia syndrome, and to gain insight into the pathogenesis of the disorder, we analyzed the localization of EXTL3 in fibroblasts derived from affected individuals and determined glycosaminoglycan concentrations in these cells as well as in urine and blood. We observed abnormal glycosaminoglycan concentrations and increased concentrations of the non-sulfated chondroitin disaccharide D0a0 and the disaccharide D0a4 in serum and urine of all analyzed affected individuals. In summary, we show that biallelic mutations in EXTL3 disturb glycosaminoglycan synthesis and thus lead to a recognizable syndrome characterized by variable expression of skeletal, neurological, and immunological abnormalities.

Keywords

EXTL3; T cell SCID; exostosin; heparan sulfate; neuro-immuno-skeletal dysplasia.

Figures